India.com Lifestyle Staff | Nov 29, 2023, 10:09 AM IST
The World Health Organisation has authorised Novavax updated vaccine shots for active immunization to prevent COVID-19 in individuals aged 12 and older
Shrimansi Kaushik | Dec 22, 2022, 5:08 PM IST
Serum Institute of India (SII) seeks Centre's approval for market authorisation of its COVID-19 vaccine, Covovax as a booster dose for those aged 18 years and above.
India.com News Desk | Aug 21, 2022, 7:47 AM IST
Novavax's COVID-19 vaccine Adjuvanted has been granted expanded emergency use authorisation for adolescents between 12-17 years of age.
IANS | Jul 14, 2022, 12:20 PM IST
The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for the Novavax Covid-19 vaccine in individuals 18 years of age and older.
India.com News Desk | Mar 23, 2022, 6:48 AM IST
Covovax is the fourth vaccine to receive EUA from the DCGI for use among adolescents 12 and older.
India.com News Desk | Mar 9, 2022, 5:48 PM IST
The approval from Drugs Controller General Of India's (DCGI) comes after the Subject Expert Committee on COVID-19 of the CDSCO last week recommended granting emergency use authorisation (EUA) to Covovax for those aged 12 to 17.
India.com News Desk | Feb 11, 2022, 8:21 AM IST
The Novavax vaccine is made with lab-grown copies of the spike protein that coats the coronavirus, mixed with an immune-boosting chemical. That's similar to shots used for years against other diseases such as hepatitis B.
India.com News Desk | Dec 21, 2021, 10:57 PM IST
WHO said Nuvaxovid was around 90 per cent effective at reducing symptomatic cases of COVID-19 in two major clinical studies.
Associated Press | Nov 17, 2021, 9:12 PM IST
The company said side effects were mild and included tenderness at the injection site, headache, aches and pains, and fatigue.
India.com News Desk | Oct 29, 2021, 9:26 PM IST
The SII has also submitted interim phase 2/3 clinical study report on Indian adults, the interim report of Novavax UK and USA-Mexico phase-3 clinical study and response to the queries raised by the DCGI office, along with its application.
India.com News Desk | Oct 21, 2021, 5:57 PM IST
Earlier, Adar Poonawalla had said clinical trials of COVID-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year.
India.com News Desk | Oct 1, 2021, 8:48 AM IST
Nine centres have been identified across India for this phase, including Bharati Vidyapeeth Medical College Hospital.
